Oral Switch Therapy for Infective Endocarditis
Author Information
Author(s): Barda Beatrice, Schindler Christian, Bernasconi Enos, Bongiovanni Marco
Primary Institution: Division of Infectious Diseases, Ente Ospedaliero Cantonale, Lugano, Switzerland
Hypothesis
Can an early switch from intravenous to oral antibiotic therapy improve outcomes for patients with infective endocarditis?
Conclusion
Oral switch therapy is a feasible option for clinically stable patients with infective endocarditis and may reduce relapse rates compared to intravenous treatment.
Supporting Evidence
- Oral switch therapy showed a significant reduction in relapse rates compared to intravenous treatment.
- Patients who switched to oral therapy had a shorter average length of hospital stay.
- Mortality rates were lower in the oral switch group, although not statistically significant.
- Adverse events were significantly lower in the oral treatment group compared to intravenous therapy.
Takeaway
Doctors can sometimes switch patients with heart infections from IV antibiotics to oral ones, which can be just as effective and help them go home sooner.
Methodology
A systematic review and meta-analysis of studies comparing intravenous and oral antibiotic treatments for infective endocarditis.
Potential Biases
Selection bias may affect the applicability of results to broader clinical settings.
Limitations
Few randomized trials directly compared IV and oral treatments, and outcome definitions varied across studies.
Participant Demographics
Included patients with infective endocarditis of various etiologies, including those with Staphylococcus aureus infections.
Statistical Information
P-Value
0.02
Confidence Interval
95% CI: 0.31–0.92
Statistical Significance
p=0.02
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website